Nivolumab Can Increase Survival Rate in Head and Neck Cancer Patients
Advanced head and neck cancer that is resistant to chemotherapy is highly difficult to treat. However, an immunotherapy drug called
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine